Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
AMPK: a therapeutic target of heart failure-not only metabolism regulation
Xuan Li1, Jia Liu1,2, Qingguo Lu1,3
1Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, U.S.A.
Insights
AMP-activated protein kinase (AMPK) offers cardioprotection by improving heart energy supply and regulating physiological processes. Activating AMPK may hold promise for treating heart failure (HF), warranting further clinical investigation.
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- Heart failure (HF) is a growing global health concern with high mortality rates.
- Various cardiovascular diseases contribute to HF by disrupting physiological functions.
- AMP-activated protein kinase (AMPK), a key cellular energy sensor, exhibits significant cardioprotective properties.
Purpose of the Study:
- To review the role of AMPK in heart failure pathophysiology.
- To highlight AMPK's mechanisms in improving cardiac energy metabolism and function.
- To discuss potential AMPK-targeting therapies for heart failure.
Main Methods:
- Literature review focusing on AMPK's role in cardiovascular health.
- Analysis of AMPK's impact on ATP production and physiological regulation in the heart.
- Evaluation of existing and potential clinical drugs targeting AMPK activation.
Main Results:
- AMPK enhances ATP production, boosting energy supply in failing hearts.
- AMPK activation regulates critical physiological processes essential for restoring heart function.
- Several drugs influencing AMPK show potential therapeutic value for HF.
Conclusions:
- AMPK activation presents a promising strategy for managing heart failure.
- Further clinical trials are crucial to validate AMPK manipulation for HF treatment.
- Targeting AMPK could offer a novel therapeutic avenue for cardiovascular diseases.
Abstract:
Heart failure (HF) is a serious disease with high mortality. The incidence of this disease has continued to increase over the past decade. All cardiovascular diseases causing dysfunction of various physiological processes can result in HF. AMP-activated protein kinase (AMPK), an energy sensor, has pleiotropic cardioprotective effects and plays a critical role in the progression of HF. In this review, we highlight that AMPK can not only improve the energy supply in the failing heart by promoting ATP production, but can also regulate several important physiological processes to restore heart function. In addition, we discuss some aspects of some potential clinical drugs which have effects on AMPK activation and may have value in treating HF. More studies, especially clinical trials, should be done to evaluate manipulation of AMPK activation as a potential means of treating HF.
Related Concept Videos
Regulation of Metabolism
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics

